Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 45 of 102, showing 5 Applications out of 508 total, starting on record 221, ending on 225

# Protocol No Study Title Investigator(s) & Site(s)

221.

ECCT/19/04/01   A study to determine if a new shigella vaccine (Shigella4V) is safe, induces immunity and the best dose among Kenyan infants.
    Safety and immunogenicity of a Shigella-tetravalent bioconjugate vaccine: A phase 1/2 randomized controlled and age descending study including dose finding in 9-month-old infants   
Principal Investigator(s)
1. Mainga Hamaluba
2. Kosgei Josphat
Site(s) in Kenya
1. KEMRI-United States Army Medical Research Unit-Kenya, Kericho (Kericho county)
2. KEMRI Wellcome Trust Research Program-CGMR-C (Kilifi county)
 
View

222.

ECCT/19/04/02   NADIA \"Nucleosides And Darunavir/Dolutegravir In Africa\"
    A randomised controlled trial of darunavir versus dolutegravir and tenofovir versus zidovudine in second-line antiretroviral therapy regimens for the public health approach in sub-Saharan Africa   
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
Moi University Clinical Research Centre
 
View

223.

ECCT/18/06/04   RANDOMIZED CONTROLLED TRIAL OF STEPPED UP VITAMIN A SUPPLEMENTATION DOSE ON IMMUNE RESPONSES AMONG INFANTS 6-12 MONTHS AT BUSIA LEVEL 4 HOSPITAL IN BUSIA COUNTY, KENYA
    BUSIA LEVEL IV HOSPITAL   
Principal Investigator(s)
1. BENARD OCHIENG WESONGA
Site(s) in Kenya
Busia Level IV Hospital
 
View

224.

ECCT/23/09/05   LCCC 2236 Study
    LCCC  2236: Phase I study of self-administered Artesunate pessaries (vaginal inserts) for treatment of cervical precancer in HIV positive and HIV-negative women in Kenya    
Principal Investigator(s)
1. Chemtai Mungo
2. Jackton Omoto
Site(s) in Kenya
FACES, Lumumba Sub-county Hospital
 
View

225.

ECCT/20/07/01   Convalescent plasma trial
    A randomized control trial comparing convalescent plasma therapy plus standard treatment versus standard treatment alone in patients with severe COVID-19 pneumonia at a tertiary hospital   
Principal Investigator(s)
1. Dr Isaac Adembesa Kadambi
Site(s) in Kenya
Kenyatta University Teaching Referral and Research Hospital
 
View